Free tool
Stocks above their 200-day average
We cover 50 companies trading above their own 200-day average. The median market value in the group is $1.11B. Across the group, the median move over the past trading day is −0.07%. 100% of the 50 with a 200-day average trade above it. Price change over the past year runs from −28.4% to +178.9% across the middle 80 percent of the group, with a median of +10.2%.
Other lists in this group
Table
50 of 10,735 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| HQY | HealthEquity, Inc. | $8.75B | Mid cap | +18.69% | Aug 27, 2026 |
| RHC.AX | Ramsay Health Care Limited | $8.27B | Mid cap | +50.11% | Aug 27, 2026 |
| GETI-B.ST | Getinge AB (publ) | $7.01B | Mid cap | +20.89% | Oct 21, 2026 |
| SECT-B.ST | Sectra AB (publ) | $5.63B | Mid cap | −17.02% | Sep 4, 2026 |
| NRIX | Nurix Therapeutics, Inc. | $2.77B | Mid cap | +179.69% | Oct 8, 2026 |
| NEOG | Neogen Corporation | $2.54B | Mid cap | +103.83% | Oct 8, 2026 |
| 3549.T | Kusuri No Aoki Holdings Co., Ltd. | $2.44B | Mid cap | +5.23% | Oct 1, 2026 |
| NBTX | Nanobiotix S.A. | $2.26B | Mid cap | +394.99% | Sep 29, 2026 |
| MSB.AX | Mesoblast Limited | $2.25B | Mid cap | +1.03% | Aug 27, 2026 |
| MESO | Mesoblast Limited | $2.23B | Mid cap | +4.47% | Aug 27, 2026 |
| EKTA-B.ST | Elekta AB (publ) | $2.20B | Mid cap | +26.10% | Aug 27, 2026 |
| ALIF-B.ST | AddLife AB (publ) | $2.08B | Mid cap | −7.20% | Oct 21, 2026 |
| NANO.PA | Nanobiotix S.A. | $2.05B | Mid cap | +358.21% | Sep 29, 2026 |
| VIMIAN.ST | Vimian Group AB (publ) | $1.99B | Small cap | +12.01% | Oct 22, 2026 |
| EMBLA.CO | Embla Medical hf. | $1.93B | Small cap | −6.94% | Oct 20, 2026 |
| HCSG | Healthcare Services Group, Inc. | $1.57B | Small cap | +47.05% | Oct 21, 2026 |
| BONEX.ST | Bonesupport Holding AB (publ) | $1.57B | Small cap | −28.26% | Oct 22, 2026 |
| KMTS | Kestra Medical Technologies, Ltd. | $1.56B | Small cap | +47.61% | Sep 14, 2026 |
| INNV | InnovAge Holding Corp. | $1.48B | Small cap | +178.79% | Sep 8, 2026 |
| GDS.PA | Ramsay Générale de Santé SA | $1.42B | Small cap | +9.50% | Oct 16, 2026 |
| 9627.T | Ain Holdings Inc. | $1.38B | Small cap | +2.85% | Sep 14, 2026 |
| CHEMM.CO | ChemoMetec A/S | $1.33B | Small cap | −3.94% | Sep 10, 2026 |
| SPI.L | Spire Healthcare Group plc | $1.28B | Small cap | +7.25% | Sep 9, 2026 |
| BIOG-B.ST | BioGaia AB (publ) | $1.23B | Small cap | +13.96% | Oct 22, 2026 |
| CVSG.L | CVS Group plc | $1.20B | Small cap | +2.05% | Sep 24, 2026 |
| GXI.DE | Gerresheimer AG | $1.02B | Small cap | −39.73% | Aug 27, 2026 |
| 7730.T | Mani, Inc. | $994.58M | Small cap | +29.48% | Oct 15, 2026 |
| XVIVO.ST | Xvivo Perfusion AB (publ) | $929.27M | Small cap | +59.31% | Oct 22, 2026 |
| MCAP.ST | MedCap AB (publ) | $864.73M | Small cap | −10.28% | Oct 23, 2026 |
| GNFT.PA | Genfit S.A. | $830.56M | Small cap | +310.45% | Sep 29, 2026 |
| ARJO-B.ST | Arjo AB (publ) | $802.95M | Small cap | −15.25% | Oct 22, 2026 |
| ANGO | AngioDynamics, Inc. | $648.51M | Small cap | +56.74% | Oct 1, 2026 |
| MEDI.OL | Medistim ASA | $512.66M | Small cap | +4.43% | Oct 23, 2026 |
| NRC | NRC Health | $487.06M | Small cap | +45.92% | Oct 26, 2026 |
| RZLT | Rezolute, Inc. | $485.31M | Small cap | −30.00% | Sep 16, 2026 |
| BNTC | Benitec Biopharma Inc. | $442.48M | Small cap | +0.16% | Sep 22, 2026 |
| NIOX.L | NIOX Group Plc | $392.35M | Small cap | −9.49% | Sep 29, 2026 |
| CRNA.OL | Circio Holding ASA | $384.19M | Small cap | +1733.85% | Aug 31, 2026 |
| HUM.ST | Humana AB (publ) | $350.23M | Small cap | +81.84% | Oct 22, 2026 |
| TRMED.OL | Thor Medical ASA | $268.94M | Small cap | +135.13% | Aug 28, 2026 |
| IPHA | Innate Pharma S.A. | $253.56M | Small cap | +2.86% | Sep 17, 2026 |
| IPH.PA | Innate Pharma S.A. | $240.15M | Small cap | +1.19% | Sep 17, 2026 |
| UTMD | Utah Medical Products, Inc. | $225.70M | Small cap | +17.76% | Oct 22, 2026 |
| HITI | High Tide Inc. | $221.43M | Small cap | −30.00% | Sep 14, 2026 |
| PDEX | Pro-Dex, Inc. | $203.83M | Small cap | +40.31% | Aug 27, 2026 |
| SEDANA.ST | Sedana Medical AB (publ) | $132.45M | Small cap | −22.05% | Oct 22, 2026 |
| ANIX | Anixa Biosciences, Inc. | $122.65M | Small cap | +22.20% | Sep 9, 2026 |
| ONCIN.OL | Oncoinvent ASA | $43.71M | Micro cap | +10.90% | Aug 27, 2026 |
| INTEG-B.ST | Integrum AB (publ) | $24.72M | Micro cap | −79.55% | Sep 3, 2026 |
| INM | InMed Pharmaceuticals Inc. | $7.64M | Micro cap | −36.44% | Sep 23, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.